Jimmy and Roya chat on the industry changes from this past year. They stroll through key points of the FDA Approval for Lotemax: Eysuvis, FDA Approval for OrthoKeratology for Myopia Management, and Color Vision Testing.
Jimmy and Roya set the stage for Dr Cory Collier to teach the magic of scleral lenses. The team steps behind the curtain to learn more about profitability, meeting patient needs, and just how amazing the scleral lens truly is. The solution is clear.
Jimmy and Roya have a great conversation with Dr Bill Reynolds and Dr Bob Layman. The team gets to the heart of what the AOA provides and how their goal is to be your biggest resource. This episode is loaded with insight from two of the AOA’s top dogs, although one would consider himself more of a race horse.
Support for this activity has been made possible through an educational grant from Allergan.
James Deom OD MPH FAAO FSLS Adjunct Faculty at Massachusetts College of Pharmacy and Health Sciences
Roya Habibi, OD, FAAO, FSLS Eye Associates Northwest PC Director, Center for Eye Comfort
With Special Guest Presenter:
Richard A. Adler, MD Belcara Health Premier Multispecialty Center Director, Ophthalmology Services Cornea and External Disease Specialist Wilmer Eye Institute, Johns Hopkins Medical School (2005-present) Assistant Professor of Ophthalmology Instructor, Ophthalmology Clerkship, School of Medicine
This activity has been designed to meet the educational needs of optometrists and ophthalmologists. Other healthcare providers may also participate.
Upon completing this activity, participants should be better able to:
Describe the specific process by which glaucoma occurs
List the risk factors for glaucoma
List the currently available instruments useful for identifying and monitoring glaucoma and glaucoma progression
Identify the current and emerging treatment options for glaucoma
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and the Institute for Continuing Healthcare Education. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc. designates this enduring activity for a maximum of 1.00 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Institute for Continuing Healthcare Education (Institute) and American Academy of CME, Inc., (Academy) The Institute is accredited by the American Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute designates this activity for 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
According to the disclosure policy of the Academy and the Institute, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
James Deom, OD discloses: Consultant for: Valley Contax, Bausch Health, AbbVie, Sun Ophthalmics, Dompe, Physician Recommended Neutreceuticals, Biotissue, Versant Health
Roya Habibi, OD discloses: Consultant for: Valley Contax
Richard A. Adler, MD discloses: Consultant for: Allergan, Lumenis, RVL, Kala, and Tarsus Speaker’s Bureau for: Allergan, Lumenis, and RVL
The planners have no relevant financial relationships with any commercial interests.
This activity will review off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or the Institute. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Method Of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive credit for your participation, please complete the post-test and program evaluation. Your certificate of credit or participation will be emailed to you within 24 hours.
Any questions about this activity or if you do not receive your certificate, please contact: [email protected]